Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Vacuna acelular")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 337

  • Page / 14
Export

Selection :

  • and

Les nouveaux vaccins: coquelucheux acellulaire, hexavalent et vaccins conjuguésSENTERRE, J.Louvain médical. 2003, Vol 122, Num 5, pp S181-S186, issn 0024-6956Conference Paper

Les vaccins coquelucheux acellulaires : l'expérience suédoiseGRANSTRÖM, M.Médecine & enfance. 2001, Vol 21, Num 8, pp 5-6, issn 0291-0233, SUPConference Paper

Le vaccin coquelucheux acellulaire à trois composants induit une immunité aussi longue que le vaccin à germes entiersGUISO, N.Médecine & enfance. 2007, Vol 27, Num 7, pp 370-371, issn 0291-0233, 2 p., CAH2Article

Different Effects of Whole-Cell and Acellular Vaccines on Bordetella TransmissionSMALLRIDGE, William E; ROLIN, Olivier Y; JACOBS, Nathan T et al.The Journal of infectious diseases. 2014, Vol 209, Num 12, pp 1981-1988, issn 0022-1899, 8 p.Article

What's Wrong With Acellular Pertussis Vaccines? : YOUTH AND CHILDREN: VACCINES UPDATEWIEDERMANN, Bernhard L.Clinical therapeutics. 2013, Vol 35, Num 2, pp 115-118, issn 0149-2918, 4 p.Article

Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assayFRY, Norman K; LITT, David J; DUNCAN, John et al.Journal of medical microbiology. 2013, Vol 62, Num 9, pp 1281-1289, issn 0022-2615, 9 p.Article

Development of an IgY-based rocket-immunoelectrophoresis for identity monitoring of Pertussis vaccinesMATHEIS, Walter; SCHADE, Rudiger.Journal of immunological methods. 2011, Vol 369, Num 1-2, pp 125-132, issn 0022-1759, 8 p.Article

Cross-Species Protection Mediated by a Bordetella bronchiseptica Strain Lacking Antigenic Homologs Present in Acellular Pertussis VaccinesSUKUMAR, Neelima; PARISE SLOAN, Gina; CONOVER, Matt S et al.Infection and immunity. 2010, Vol 78, Num 5, pp 2008-2016, issn 0019-9567, 9 p.Article

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumanniiMCCONNELL, Michael J; RUMBO, Carlos; BOU, German et al.Vaccine. 2011, Vol 29, Num 34, pp 5705-5710, issn 0264-410X, 6 p.Article

Modified intra-cerebral challenge assay for acellular pertussis vaccines: Comparisons among whole cell and acellular vaccinesGAINES-DAS, R; HORIUCHI, Y; ZHANG, S. M et al.Vaccine. 2009, Vol 27, Num 49, pp 6824-6832, issn 0264-410X, 9 p.Article

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigensSCHEIFELE, David W; HALPERIN, Scott A; FERGUSON, Alexander C et al.Vaccine. 2001, Vol 19, Num 32, pp 4720-4726, issn 0264-410XArticle

Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccinationSMITS, Kaatje; POTTIER, Gaelle; SMET, Julie et al.Vaccine. 2013, Vol 32, Num 1, pp 111-118, issn 0264-410X, 8 p.Article

Comparison of the tolerability of an acellular pertussis-containing vaccine given as the fifth booster dose in differently primed childrenKEMMEREN, Jeanet M; TIMMER, Sylvana S; VAN DER MAAS, Nicoline A. T et al.Vaccine. 2011, Vol 29, Num 26, pp 4373-4377, issn 0264-410X, 5 p.Article

Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidateASENSIO, Cristian J. A; GAILLARD, Maria Emilia; MORENO, Griselda et al.Vaccine. 2011, Vol 29, Num 8, pp 1649-1656, issn 0264-410X, 8 p.Article

Vaccins coquelucheux acellulaires : combien de composants ? = Acellular pertussis vaccines: how many components?GUISO, Nicole.MTP. Médecine thérapeutique pédiatrie. 2001, Vol 4, Num MAI, pp 16-20, issn 1286-5494, HS1Article

A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoidsNAKAYAMA, T; AIZAWA, C; KUNO-SAKAI, H et al.Journal of allergy and clinical immunology. 1999, Vol 103, Num 2, pp 321-325, issn 0091-6749, 1Article

Safety of a Tetanus-Diphtheria-Acellular Pertussis Vaccine When Used Off-Label in an Elderly PopulationTSENG, Hung Fu; SY, Lina S; WEINTRAUB, Eric et al.Clinical infectious diseases. 2013, Vol 56, Num 3, pp 315-321, issn 1058-4838, 7 p.Article

A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type bVEREZ-BENCOMO, V; FERNANDEZ-SANTANA, V; VILLAR, Annette et al.Science (Washington, D.C.). 2004, Vol 305, Num 5683, pp 522-525, issn 0036-8075, 4 p.Article

Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge modelWATANABE, Mineo; KOMATSU, Eiii; ABE, Katsuyo et al.Vaccine. 2002, Vol 20, Num 9-10, pp 1429-1434, issn 0264-410XArticle

Immunogenicity and reactogenicity of acellular diphtheria/tetanus/pertussis vaccines given as a pre-school booster : effect of simultaneous administration of MMRMILLER, E; WAIGHT, P; LAURICHESSE, H et al.Vaccine. 2001, Vol 19, Num 28-29, pp 3904-3911, issn 0264-410XArticle

Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccinationPRELOG, M; ALMANZAR, G; RIEBER, N et al.Vaccine. 2013, Vol 31, Num 2, pp 387-393, issn 0264-410X, 7 p.Article

Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid componentJACKSON, Lisa A; FALLS, Sherry; ONCHEE YU et al.The Journal of infectious diseases. 2001, Vol 183, Num 11, pp 1698-1700, issn 0022-1899Article

Heterologous prime-boost immunization with live attenuated B. pertussis BPZE1 followed by acellular pertussis vaccine in miceFEUNOU, Pascal F; KAMMOUN, Hana; DEBRIE, Anne-Sophie et al.Vaccine. 2014, Vol 32, Num 34, pp 4281-4288, issn 0264-410X, 8 p.Article

Cost―benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)YAO DING; YEH, Sylvia H; MINK, Chris Anna M et al.Vaccine. 2013, Vol 31, Num 22, pp 2558-2564, issn 0264-410X, 7 p.Article

Economic impact of the introduction of an acellular pertussis vaccine in Canada: A 6-year analysisISKEDJIAN, Michael; DE SERRES, Gaston; EINARSON, Thomas R et al.Vaccine. 2010, Vol 28, Num 3, pp 714-723, issn 0264-410X, 10 p.Article

  • Page / 14